Owner Novartis AG

Inventors Furet, Pascal; Jacob, Sandra; Manley, Paul William; Breitenstein, Werner

Agent Davies Collison Cave

Pub. Number AU-B-2003249962

PCT Number PCT/EP03/07198

PCT Pub. Number WO2004/005281

Priority 0215676.8 05.07.02 GB; 0229893.3 20.12.02 BG

Filing date 4 July 2003

Wipo publication date 23 January 2004

Acceptance publication date 28 February 2008

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group